The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy
View/ Open
Author
Sancey, L
Lux, F
Kotb, S
Roux, S
Dufort, S
Bianchi, A
Crémillieux, Y
Fries, P
Coll, J-L
Rodriguez-Lafrasse, C
Janier, M
Dutreix, M
Barberi-Heyob, M
Boschetti, F
Denat, F
Louis, C
Porcel, E
Lacombe, S
Le Duc, G
Deutsch, E
Perfettini, J-L
Detappe, A
Verry, C
Berbeco, R
Butterworth, K T
McMahon, S J
Prise, K M
Perriat, P
Tillement, O
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1259/bjr.20140134Metadata
Show full item recordCitation
Sancey, L., F. Lux, S. Kotb, S. Roux, S. Dufort, A. Bianchi, Y. Crémillieux, et al. 2014. “The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy.” The British Journal of Radiology 87 (1041): 20140134. doi:10.1259/bjr.20140134. http://dx.doi.org/10.1259/bjr.20140134.Abstract
A new efficient type of gadolinium-based theranostic agent (AGuIX®) has recently been developed for MRI-guided radiotherapy (RT). These new particles consist of a polysiloxane network surrounded by a number of gadolinium chelates, usually 10. Owing to their small size (<5 nm), AGuIX typically exhibit biodistributions that are almost ideal for diagnostic and therapeutic purposes. For example, although a significant proportion of these particles accumulate in tumours, the remainder is rapidly eliminated by the renal route. In addition, in the absence of irradiation, the nanoparticles are well tolerated even at very high dose (10 times more than the dose used for mouse treatment). AGuIX particles have been proven to act as efficient radiosensitizers in a large variety of experimental in vitro scenarios, including different radioresistant cell lines, irradiation energies and radiation sources (sensitizing enhancement ratio ranging from 1.1 to 2.5). Pre-clinical studies have also demonstrated the impact of these particles on different heterotopic and orthotopic tumours, with both intratumoural or intravenous injection routes. A significant therapeutical effect has been observed in all contexts. Furthermore, MRI monitoring was proven to efficiently aid in determining a RT protocol and assessing tumour evolution following treatment. The usual theoretical models, based on energy attenuation and macroscopic dose enhancement, cannot account for all the results that have been obtained. Only theoretical models, which take into account the Auger electron cascades that occur between the different atoms constituting the particle and the related high radical concentrations in the vicinity of the particle, provide an explanation for the complex cell damage and death observed.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453146/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:22857018
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)